Assessment of the Aromatherapy to Alleviate Peri Operative Anxiety in Ambulatory Elective Upper Limb Surgery Under Loco-regional Anesthesia

NCT ID: NCT03583801

Last Updated: 2022-10-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

294 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-14

Study Completion Date

2023-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

AROMA study is a randomised controlled parallel-group single-site study. Patients randomized in the experimental group benefit from the aromatherapy at their arrival in the operating theatre in the recovery room. 2 drops of essential oils are applied on a compress placed next to the head of the patient. This compress is kept until the patient is leaving the operating theatre. Patients randomized in the control group don't benefit from the aromatherapy. The anxiety evolution is measured in both groups with the Amsterdam Preoperative Anxiety and Information Scale (APAIS). The hypothesis is that aromatherapy alleviate peri operative anxiety during an ambulatory elective upper limb surgery under loco-regional anesthesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

aromatherapy group

The patient has to choose an essential oil among the 3 proposed :

* sweet orange (Citrus sinensis L. Persoon)
* fine lavender (Lavandula angustifolia P. Miller)
* little seed from the mandarin tree (Citrus reticulata blanco)

Group Type EXPERIMENTAL

Olfactory aromatherapy

Intervention Type OTHER

2 drops of the essential oil choosed by the patient are applied on a compress placed next to his head from his arrival in the recovery room to his leaving from the operating theatre. The method of administration is the respiratory tract..

without aromatherapy

Group Type PLACEBO_COMPARATOR

without aromatherapy

Intervention Type OTHER

no intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Olfactory aromatherapy

2 drops of the essential oil choosed by the patient are applied on a compress placed next to his head from his arrival in the recovery room to his leaving from the operating theatre. The method of administration is the respiratory tract..

Intervention Type OTHER

without aromatherapy

no intervention

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Inhalation of essential oils

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient admitted in Hospital Centre for an ambulatory elective upper limb " fast track " surgery
* Patient with loco-regional anesthesia
* Patient categorized 3 or less according to the American Society of Anesthesiologists (ASA) score
* The patient must have given his written consent to participate in the study
* Patient - insured under the French social security system
* Patient prepared to comply with all the terms of the study and its length

Exclusion Criteria

* Epileptic patients
* Asthmatic patients
* Patients with cognitive disorders ( Mini Mental Status below 15)
* Psychiatric disorders : current depression or bipolar disease or anxiety disorders or psychotic disorders according to DSM-V classification
* American Society of Anesthesiologists score strictly superior to 3
* Preoperative chronic pain : neuropathic pain, fibromyalgia, polyarthritis
* Pregnant or breastfeeding woman
* Patient unable to receive an informed consent and to comply with all the terms of the study
* Patient without any social insurance
* Refusal to sign the consent
* Patient under legal protection
* Patient in emergency (unstable clinical state)
* Patient unable to read or write french
* Patient enrolled in an other clinical trial
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Lille

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cécile RIVOAL

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Lille

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre hospitalier

Valenciennes, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Cécile RIVOAL, MD

Role: CONTACT

3.27.14.50.61 ext. +33

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018-A00642-53

Identifier Type: OTHER

Identifier Source: secondary_id

2017_58

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.